Research ExplorerPublicationsFactors Associated with Receiving Biologics or Classic Syste...

Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries

Standard

Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. / Davila-Seijo, Paula; Garcia-Doval, Ignacio; Naldi, Luigi; Cazzaniga, Simone; Augustin, Matthias; Rustenbach, Stephan J; Daudén, Esteban; Dam, Tomas Norman; Baker, Chris; Spuls, Phyllis I; Stern, Robert S; Cohen, Arnon D.

In: ACTA DERM-VENEREOL, Vol. 97, No. 4, 06.04.2017, p. 516-518.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Davila-Seijo, P, Garcia-Doval, I, Naldi, L, Cazzaniga, S, Augustin, M, Rustenbach, SJ, Daudén, E, Dam, TN, Baker, C, Spuls, PI, Stern, RS & Cohen, AD 2017, 'Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries', ACTA DERM-VENEREOL, vol. 97, no. 4, pp. 516-518. https://doi.org/10.2340/00015555-2586

APA

Davila-Seijo, P., Garcia-Doval, I., Naldi, L., Cazzaniga, S., Augustin, M., Rustenbach, S. J., Daudén, E., Dam, T. N., Baker, C., Spuls, P. I., Stern, R. S., & Cohen, A. D. (2017). Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. ACTA DERM-VENEREOL, 97(4), 516-518. https://doi.org/10.2340/00015555-2586

Vancouver

Davila-Seijo P, Garcia-Doval I, Naldi L, Cazzaniga S, Augustin M, Rustenbach SJ et al. Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. ACTA DERM-VENEREOL. 2017 Apr 6;97(4):516-518. https://doi.org/10.2340/00015555-2586

Bibtex

@article{b09cbbec53274012b489d8aceda0da0c,
title = "Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries",
keywords = "Biological Products, Europe, Evidence-Based Medicine, Healthcare Disparities, Humans, Immunosuppressive Agents, Israel, Patient Selection, Practice Patterns, Physicians', Psoriasis, Registries, Severity of Illness Index, Treatment Outcome, Comparative Study, Journal Article, Multicenter Study",
author = "Paula Davila-Seijo and Ignacio Garcia-Doval and Luigi Naldi and Simone Cazzaniga and Matthias Augustin and Rustenbach, {Stephan J} and Esteban Daud{\'e}n and Dam, {Tomas Norman} and Chris Baker and Spuls, {Phyllis I} and Stern, {Robert S} and Cohen, {Arnon D}",
note = "Editorial Material",
year = "2017",
month = apr,
day = "6",
doi = "10.2340/00015555-2586",
language = "English",
volume = "97",
pages = "516--518",
journal = "ACTA DERM-VENEREOL",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "4",

}

RIS

TY - JOUR

T1 - Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries

AU - Davila-Seijo, Paula

AU - Garcia-Doval, Ignacio

AU - Naldi, Luigi

AU - Cazzaniga, Simone

AU - Augustin, Matthias

AU - Rustenbach, Stephan J

AU - Daudén, Esteban

AU - Dam, Tomas Norman

AU - Baker, Chris

AU - Spuls, Phyllis I

AU - Stern, Robert S

AU - Cohen, Arnon D

N1 - Editorial Material

PY - 2017/4/6

Y1 - 2017/4/6

KW - Biological Products

KW - Europe

KW - Evidence-Based Medicine

KW - Healthcare Disparities

KW - Humans

KW - Immunosuppressive Agents

KW - Israel

KW - Patient Selection

KW - Practice Patterns, Physicians'

KW - Psoriasis

KW - Registries

KW - Severity of Illness Index

KW - Treatment Outcome

KW - Comparative Study

KW - Journal Article

KW - Multicenter Study

U2 - 10.2340/00015555-2586

DO - 10.2340/00015555-2586

M3 - Other (editorial matter etc.)

C2 - 27882386

VL - 97

SP - 516

EP - 518

JO - ACTA DERM-VENEREOL

JF - ACTA DERM-VENEREOL

SN - 0001-5555

IS - 4

ER -